Hope, Health and Heart Tickets On Sale ❤️
Hope, Health and Heart Tickets On Sale ❤️
Heart rhythm disorders (arrhythmias) affect millions of people worldwide. Atrial fibrillation and flutter, the most frequent clinically significant arrhythmias, now affect more than 50 million people globally and their prevalence has roughly doubled since 1990, with cases expected to keep rising as populations age.
We’re bringing new insights into the diagnosis and treatment of patients who are impacted by arrhythmias. In partnership with the Allina Health Minneapolis Heart Institute, one of the most comprehensive arrhythmia programs in the country, we conduct research on all types of heart rhythm disorders, ranging from those that are common to those that are rare and inherited.
Under the leadership of Dr. Jay Sengupta, the Joseph F. Novogratz Family Heart Rhythm Center works to advance the prevention and treatment of heart arrhythmias such as atrial fibrillation and sudden cardiac arrest. This center also drives innovation through research of medical devices like pacemakers and implantable cardiac defibrillators (ICDs) that are important in the management of common heart rhythm conditions.
Through their extraordinary gift, the Novogratz family is making it possible for MHIF to advance care for future generations of families living with heart rhythm conditions.
Leveraging genetic research and personalized medicine to customize patient therapies.
Enhance patient safety and effectiveness of implantable cardiac rhythm devices.
Advance ablation techniques and technologies to improve treatment of atrial fibrillation.
Advance our understanding, treatment, and elimination of heart rhythm disorders worldwide.
Under the expertise of Dr. Jay Sengupta, the Genetic Arrhythmia and Cardiomyopathy Clinic (GACC) is dedicated to supporting patients and families affected by rare genetic heart rhythm disorders. Insights from our clinic are integrated into research that contributes to our understanding of the conditions.
The clinic provides personalized consultations with a dedicated cardiac genetic counselor, and is devoted to providing advanced screening techniques, highly skilled doctors, precise diagnosis and the latest treatments available to ensure the best possible outcomes for our patients.
Our team drives research to advance the understanding and treatment of heart rhythm disorders. By studying innovative therapies and preventative strategies, we empower clinicians and patients with evidence-based insights that improve rhythm management and support long-term heart health.
“I just feel like I'm really lucky; I'm thankful to be alive... I try to do a lot of outreach teaching people CPR because without it, the outcome would've been completely different. I had CPR for 20 minutes and today, I'm totally normal and living a normal life.”
—Alicia Bravo, Long QT Syndrome
Keep up to date on MHIF news, events and the latest information on heart disease treatment and prevention.